Abstract
Summary
The global Opioid Use Disorder Treatment market size is projected to grow from US$ million in 2023 to US$ million in 2030; it is expected to grow at a CAGR of % from 2024 to 2030.
LP Information, Inc. (LPI) ' newest research report, the “Opioid Use Disorder Treatment Industry Forecast” looks at past sales and reviews total world Opioid Use Disorder Treatment sales in 2023, providing a comprehensive analysis by region and market sector of projected Opioid Use Disorder Treatment sales for 2024 through 2030. With Opioid Use Disorder Treatment sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Opioid Use Disorder Treatment industry.
This Insight Report provides a comprehensive analysis of the global Opioid Use Disorder Treatment landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Opioid Use Disorder Treatment portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Opioid Use Disorder Treatment market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Opioid Use Disorder Treatment and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Opioid Use Disorder Treatment.
United States market for Opioid Use Disorder Treatment is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for Opioid Use Disorder Treatment is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for Opioid Use Disorder Treatment is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key Opioid Use Disorder Treatment players cover Trevena, Aphios, Kyowa kirin, Gamida-Cell and Novartis, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of Opioid Use Disorder Treatment market by product type, application, key manufacturers and key regions and countries.
Segmentation by type
Romiplostim
Omidubicel
Nalmefene
Others
Segmentation by application
Hospital
Drug Stores
Other
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Trevena
Aphios
Kyowa kirin
Gamida-Cell
Novartis
Titan Pharmaceutical
Hikma Pharmaceutical
MediciNova
Alkermes
BioDelivery Sciences International
Key Questions Addressed in this Report
What is the 10-year outlook for the global Opioid Use Disorder Treatment market?
What factors are driving Opioid Use Disorder Treatment market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Opioid Use Disorder Treatment market opportunities vary by end market size?
How does Opioid Use Disorder Treatment break out type, application?
LP Information, Inc. (LPI) ' newest research report, the “Opioid Use Disorder Treatment Industry Forecast” looks at past sales and reviews total world Opioid Use Disorder Treatment sales in 2023, providing a comprehensive analysis by region and market sector of projected Opioid Use Disorder Treatment sales for 2024 through 2030. With Opioid Use Disorder Treatment sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Opioid Use Disorder Treatment industry.
This Insight Report provides a comprehensive analysis of the global Opioid Use Disorder Treatment landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Opioid Use Disorder Treatment portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Opioid Use Disorder Treatment market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Opioid Use Disorder Treatment and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Opioid Use Disorder Treatment.
United States market for Opioid Use Disorder Treatment is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for Opioid Use Disorder Treatment is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for Opioid Use Disorder Treatment is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key Opioid Use Disorder Treatment players cover Trevena, Aphios, Kyowa kirin, Gamida-Cell and Novartis, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of Opioid Use Disorder Treatment market by product type, application, key manufacturers and key regions and countries.
Segmentation by type
Romiplostim
Omidubicel
Nalmefene
Others
Segmentation by application
Hospital
Drug Stores
Other
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Trevena
Aphios
Kyowa kirin
Gamida-Cell
Novartis
Titan Pharmaceutical
Hikma Pharmaceutical
MediciNova
Alkermes
BioDelivery Sciences International
Key Questions Addressed in this Report
What is the 10-year outlook for the global Opioid Use Disorder Treatment market?
What factors are driving Opioid Use Disorder Treatment market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Opioid Use Disorder Treatment market opportunities vary by end market size?
How does Opioid Use Disorder Treatment break out type, application?
Table of Contents
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Opioid Use Disorder Treatment Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Opioid Use Disorder Treatment by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Opioid Use Disorder Treatment by Country/Region, 2019, 2023 & 2030
2.2 Opioid Use Disorder Treatment Segment by Type
2.2.1 Romiplostim
2.2.2 Omidubicel
2.2.3 Nalmefene
2.2.4 Others
2.3 Opioid Use Disorder Treatment Sales by Type
2.3.1 Global Opioid Use Disorder Treatment Sales Market Share by Type (2019-2024)
2.3.2 Global Opioid Use Disorder Treatment Revenue and Market Share by Type (2019-2024)
2.3.3 Global Opioid Use Disorder Treatment Sale Price by Type (2019-2024)
2.4 Opioid Use Disorder Treatment Segment by Application
2.4.1 Hospital
2.4.2 Drug Stores
2.4.3 Other
2.5 Opioid Use Disorder Treatment Sales by Application
2.5.1 Global Opioid Use Disorder Treatment Sale Market Share by Application (2019-2024)
2.5.2 Global Opioid Use Disorder Treatment Revenue and Market Share by Application (2019-2024)
2.5.3 Global Opioid Use Disorder Treatment Sale Price by Application (2019-2024)
3 Global Opioid Use Disorder Treatment by Company
3.1 Global Opioid Use Disorder Treatment Breakdown Data by Company
3.1.1 Global Opioid Use Disorder Treatment Annual Sales by Company (2019-2024)
3.1.2 Global Opioid Use Disorder Treatment Sales Market Share by Company (2019-2024)
3.2 Global Opioid Use Disorder Treatment Annual Revenue by Company (2019-2024)
3.2.1 Global Opioid Use Disorder Treatment Revenue by Company (2019-2024)
3.2.2 Global Opioid Use Disorder Treatment Revenue Market Share by Company (2019-2024)
3.3 Global Opioid Use Disorder Treatment Sale Price by Company
3.4 Key Manufacturers Opioid Use Disorder Treatment Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Opioid Use Disorder Treatment Product Location Distribution
3.4.2 Players Opioid Use Disorder Treatment Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Opioid Use Disorder Treatment by Geographic Region
4.1 World Historic Opioid Use Disorder Treatment Market Size by Geographic Region (2019-2024)
4.1.1 Global Opioid Use Disorder Treatment Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Opioid Use Disorder Treatment Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Opioid Use Disorder Treatment Market Size by Country/Region (2019-2024)
4.2.1 Global Opioid Use Disorder Treatment Annual Sales by Country/Region (2019-2024)
4.2.2 Global Opioid Use Disorder Treatment Annual Revenue by Country/Region (2019-2024)
4.3 Americas Opioid Use Disorder Treatment Sales Growth
4.4 APAC Opioid Use Disorder Treatment Sales Growth
4.5 Europe Opioid Use Disorder Treatment Sales Growth
4.6 Middle East & Africa Opioid Use Disorder Treatment Sales Growth
5 Americas
5.1 Americas Opioid Use Disorder Treatment Sales by Country
5.1.1 Americas Opioid Use Disorder Treatment Sales by Country (2019-2024)
5.1.2 Americas Opioid Use Disorder Treatment Revenue by Country (2019-2024)
5.2 Americas Opioid Use Disorder Treatment Sales by Type
5.3 Americas Opioid Use Disorder Treatment Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Opioid Use Disorder Treatment Sales by Region
6.1.1 APAC Opioid Use Disorder Treatment Sales by Region (2019-2024)
6.1.2 APAC Opioid Use Disorder Treatment Revenue by Region (2019-2024)
6.2 APAC Opioid Use Disorder Treatment Sales by Type
6.3 APAC Opioid Use Disorder Treatment Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Opioid Use Disorder Treatment by Country
7.1.1 Europe Opioid Use Disorder Treatment Sales by Country (2019-2024)
7.1.2 Europe Opioid Use Disorder Treatment Revenue by Country (2019-2024)
7.2 Europe Opioid Use Disorder Treatment Sales by Type
7.3 Europe Opioid Use Disorder Treatment Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Opioid Use Disorder Treatment by Country
8.1.1 Middle East & Africa Opioid Use Disorder Treatment Sales by Country (2019-2024)
8.1.2 Middle East & Africa Opioid Use Disorder Treatment Revenue by Country (2019-2024)
8.2 Middle East & Africa Opioid Use Disorder Treatment Sales by Type
8.3 Middle East & Africa Opioid Use Disorder Treatment Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Opioid Use Disorder Treatment
10.3 Manufacturing Process Analysis of Opioid Use Disorder Treatment
10.4 Industry Chain Structure of Opioid Use Disorder Treatment
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Opioid Use Disorder Treatment Distributors
11.3 Opioid Use Disorder Treatment Customer
12 World Forecast Review for Opioid Use Disorder Treatment by Geographic Region
12.1 Global Opioid Use Disorder Treatment Market Size Forecast by Region
12.1.1 Global Opioid Use Disorder Treatment Forecast by Region (2025-2030)
12.1.2 Global Opioid Use Disorder Treatment Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Opioid Use Disorder Treatment Forecast by Type
12.7 Global Opioid Use Disorder Treatment Forecast by Application
13 Key Players Analysis
13.1 Trevena
13.1.1 Trevena Company Information
13.1.2 Trevena Opioid Use Disorder Treatment Product Portfolios and Specifications
13.1.3 Trevena Opioid Use Disorder Treatment Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Trevena Main Business Overview
13.1.5 Trevena Latest Developments
13.2 Aphios
13.2.1 Aphios Company Information
13.2.2 Aphios Opioid Use Disorder Treatment Product Portfolios and Specifications
13.2.3 Aphios Opioid Use Disorder Treatment Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Aphios Main Business Overview
13.2.5 Aphios Latest Developments
13.3 Kyowa kirin
13.3.1 Kyowa kirin Company Information
13.3.2 Kyowa kirin Opioid Use Disorder Treatment Product Portfolios and Specifications
13.3.3 Kyowa kirin Opioid Use Disorder Treatment Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Kyowa kirin Main Business Overview
13.3.5 Kyowa kirin Latest Developments
13.4 Gamida-Cell
13.4.1 Gamida-Cell Company Information
13.4.2 Gamida-Cell Opioid Use Disorder Treatment Product Portfolios and Specifications
13.4.3 Gamida-Cell Opioid Use Disorder Treatment Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Gamida-Cell Main Business Overview
13.4.5 Gamida-Cell Latest Developments
13.5 Novartis
13.5.1 Novartis Company Information
13.5.2 Novartis Opioid Use Disorder Treatment Product Portfolios and Specifications
13.5.3 Novartis Opioid Use Disorder Treatment Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Novartis Main Business Overview
13.5.5 Novartis Latest Developments
13.6 Titan Pharmaceutical
13.6.1 Titan Pharmaceutical Company Information
13.6.2 Titan Pharmaceutical Opioid Use Disorder Treatment Product Portfolios and Specifications
13.6.3 Titan Pharmaceutical Opioid Use Disorder Treatment Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 Titan Pharmaceutical Main Business Overview
13.6.5 Titan Pharmaceutical Latest Developments
13.7 Hikma Pharmaceutical
13.7.1 Hikma Pharmaceutical Company Information
13.7.2 Hikma Pharmaceutical Opioid Use Disorder Treatment Product Portfolios and Specifications
13.7.3 Hikma Pharmaceutical Opioid Use Disorder Treatment Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 Hikma Pharmaceutical Main Business Overview
13.7.5 Hikma Pharmaceutical Latest Developments
13.8 MediciNova
13.8.1 MediciNova Company Information
13.8.2 MediciNova Opioid Use Disorder Treatment Product Portfolios and Specifications
13.8.3 MediciNova Opioid Use Disorder Treatment Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 MediciNova Main Business Overview
13.8.5 MediciNova Latest Developments
13.9 Alkermes
13.9.1 Alkermes Company Information
13.9.2 Alkermes Opioid Use Disorder Treatment Product Portfolios and Specifications
13.9.3 Alkermes Opioid Use Disorder Treatment Sales, Revenue, Price and Gross Margin (2019-2024)
13.9.4 Alkermes Main Business Overview
13.9.5 Alkermes Latest Developments
13.10 BioDelivery Sciences International
13.10.1 BioDelivery Sciences International Company Information
13.10.2 BioDelivery Sciences International Opioid Use Disorder Treatment Product Portfolios and Specifications
13.10.3 BioDelivery Sciences International Opioid Use Disorder Treatment Sales, Revenue, Price and Gross Margin (2019-2024)
13.10.4 BioDelivery Sciences International Main Business Overview
13.10.5 BioDelivery Sciences International Latest Developments
14 Research Findings and Conclusion